Apollomics (APLM) Total Current Liabilities (2021 - 2025)

Apollomics (APLM) posted quarterly Total Current Liabilities of $388000.0 for Q4 2025, down 93.19% year-on-year from $5.7 million in Q4 2024, and down 40.03% on a QoQ basis from $647000.0 in Q2 2025.

Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Total Current Liabilities for 5 consecutive years, with $388000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Total Current Liabilities fell 93.19% year-over-year to $388000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $388000.0 (down 93.19% YoY) and the FY2025 annual result came in at $388000.0, down 93.19% from the prior year.
  • Total Current Liabilities slipped to $388000.0 in Q4 2025 per APLM's latest filing, from $647000.0 in the prior quarter.
  • Over the last five years, Total Current Liabilities for APLM reached as high as $64.1 million in Q4 2022 and fell as low as $388000.0 in Q4 2025.
  • A 5-year average of $25.7 million and a median of $17.7 million in 2021 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities surged 372.99% — and 2025, when it sank 97.05%.
  • Year by year, Total Current Liabilities stood at $13.6 million in 2021, then jumped by 372.99% to $64.1 million in 2022, then slumped by 34.76% to $41.8 million in 2023, then sank by 86.38% to $5.7 million in 2024, then sank by 93.19% to $388000.0 in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $388000.0, $647000.0, and $5.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Apollomics 2.66 Bn 2.66 Bn - 388,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 388,000.00
Jun 30, 2025 647,000.00
Dec 31, 2024 5.70 Mn
Jun 30, 2024 21.92 Mn
Dec 31, 2023 41.83 Mn
Jun 30, 2023 57.24 Mn
Dec 31, 2022 64.12 Mn
Dec 31, 2021 13.56 Mn